ConductScience.org, home

Trial · NCT06682260

Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure

NCT06682260, Phase 4, Completed, Copenhagen University Hospital, Hvidovre

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure. Trials, record NCT06682260. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06682260

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure
NCT number
NCT06682260
Status
Completed
Phases
Phase 4
Enrollment
21 participants, actual
Lead sponsor
Copenhagen University Hospital, Hvidovre
Conditions
Acute Heart Failure (AHF)
Interventions
Nitroglycerin (NTG)
First posted
2024-11-12
Last updated
2026-03-18

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryStroke volumeFrom initiation of nitroglycerin infusion at time zero until study termination at 180 minutes.Change in stroke volume (obtained from LiDCO) from baseline through vasodilation period.
SecondaryCumulated urinary output (mL)From time zero until study termination at 180 minutes.Measurement of cumulated urinary output after placement of a transurethral catheter.
SecondaryMean arterial blood pressureFrom time zero throughout the study period until termination at time 180 minutes.
SecondaryHeart rateFrom time zero throughout the study period until termination at time 180 minutes.
SecondaryCardiac outputAt baseline and at timepoints 90 minutes and 180 minutes.Measured by echocardiography.
SecondaryPeripheral perfusion indexFrom time zero throughout the study period until termination at time 180 minutes.As obtained by photoplethysmography, where a higher numerical value may indicate better peripheral tissue perfusion.
SecondarySystemic vascular resistanceFrom time zero throughout the study period until termination at time 180 minutes.\[SVR=(MAP-RAP)×80/CO\]

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06682260

GET https://conductscience.org/api/trials/v1/NCT06682260/registered